Global Hodgkin's Lymphoma Market Trends: Forecast and Key Players | Most Leading Companies - Merck & Co., Inc., Bristol Myers Squibb, F. Hoffmann-La Roche Ltd, Seagen Inc., Ono Pharmaceutical Co., Ltd

The Global Hodgkin's Lymphoma Market reached US$ 0.9 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 2.1 billion by 2031. The global Hodgkin's lymphoma market is expected to exhibit a CAGR of 9.8% during the forecast period (2024-2031)

Hodgkin's Lymphoma Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://www.datamintelligence.com/download-sample/hodgkin-lymphoma-market?kb

Hodgkin's Lymphoma is a type of cancer that originates in the lymphatic system, specifically in the lymphocytes (a type of white blood cell). It is characterized by the presence of Reed-Sternberg cells, which are abnormal cells found in the lymph nodes. Hodgkin's lymphoma typically presents as swollen lymph nodes, fever, night sweats, unexplained weight loss, and fatigue. It is relatively rare compared to other types of lymphoma and often affects younger individuals. Early diagnosis and treatment, which may include chemotherapy, radiation therapy, or stem cell transplants, significantly improve prognosis.

List of the Key Players in the Hodgkin's Lymphoma Market:

Merck & Co., Inc., Bristol Myers Squibb, F. Hoffmann-La Roche Ltd, Seagen Inc., Ono Pharmaceutical Co., Ltd., AstraZeneca, Inc., Actinium Pharmaceuticals, Inc., Pfizer Inc., Affimed GmbH and Incyte among others.

Industry Development:

On June 11, 2023, Innovent Biologics, Inc., a leading biopharmaceutical company, presented the results of a Phase 1 clinical trial for IBI322, the world's first bispecific anti-CD47/PD-L1 antibody. The study focused on patients with classic Hodgkin lymphoma who were resistant to anti-PD-(L)1 therapies. The findings were shared during an oral presentation at the 28th Annual Meeting of the American Society of Clinical Oncology (ASCO).

On May 23, 2023, the U.S. Food and Drug Administration (FDA) approved Affimed N.V.'s Investigational New Drug (IND) application for the combined use of AFM13, a first-in-class bispecific tetravalent innate cell engager (ICE), and AB-101, a clinical-stage, off-the-shelf immunotherapy from Artiva Biotherapeutics Inc. This therapy uses cryopreserved, non-genetically modified, allogeneic cord blood cells.

On May 1, 2023, Bristol Myers Squibb announced positive topline results from two clinical trials, TRANSCEND FL and TRANSCEND NHL 001, which evaluated Breyanzi (lisocabtagene maraleucel) for patients with refractory or relapsed B-cell non-Hodgkin lymphoma. Both studies met their primary endpoint, showing statistically significant and clinically meaningful responses in patients with relapsed or treatment-resistant follicular lymphoma (FL) and mantle cell lymphoma (MCL).

Research Process:

Both primary and secondary data sources have been used in the global Hodgkin's Lymphoma Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/hodgkin-lymphoma-market?kb

Segment Covered in the Hodgkin's Lymphoma Market:

By Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, Others

By Type: Nodular sclerosis Hodgkin lymphoma, Mixed cellularity Hodgkin lymphoma, Lymphocyte-rich Hodgkin lymphoma, Lymphocyte-depleted Hodgkin lymphoma

By Distribution channel: Hospitals, Clinics, Cancer centers, Others

Regional Analysis for Hodgkin's Lymphoma Market:

The regional analysis of the Hodgkin's Lymphoma Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/hodgkin-lymphoma-market?kb

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Hodgkin's Lymphoma market?

➠ Who are the leading manufacturers in the global Hodgkin's Lymphoma industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Hodgkin's Lymphoma industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Hodgkin's Lymphoma market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.